CVE-2019-14824

Description

A flaw was found in the 'deref' plugin of 389-ds-base where it could use the 'search' permission to display attribute values. In some configurations, this could allow an authenticated attacker to view private attributes, such as password hashes.

Category

6.5
CVSS
Severity: Medium
CVSS 3.1 •
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.20%
Vendor Advisory redhat.com Vendor Advisory redhat.com Vendor Advisory redhat.com
Affected: [UNKNOWN] 389-ds-base
Published at:
Updated at:

References

Link Tags
https://access.redhat.com/errata/RHSA-2019:3981 vendor advisory
https://lists.debian.org/debian-lts-announce/2019/11/msg00036.html third party advisory mailing list
https://access.redhat.com/errata/RHSA-2020:0464 vendor advisory
https://bugzilla.redhat.com/show_bug.cgi?id=CVE-2019-14824 vendor advisory issue tracking
https://lists.debian.org/debian-lts-announce/2023/04/msg00026.html

Frequently Asked Questions

What is the severity of CVE-2019-14824?
CVE-2019-14824 has been scored as a medium severity vulnerability.
How to fix CVE-2019-14824?
To fix CVE-2019-14824, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2019-14824 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2019-14824 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2019-14824?
CVE-2019-14824 affects [UNKNOWN] 389-ds-base.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.